DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,572,000
7,531,000
7,709,000
7,515,000
7,493,000
Cost of Revenue
4,966,000
4,926,000
4,719,000
4,616,000
4,657,000
Gross Profit
2,606,000
2,605,000
2,990,000
2,899,000
2,836,000
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
1,456,000
1,424,000
1,750,000
1,681,000
1,679,000
Total Operating Expenses
1,523,000
1,500,000
1,825,000
1,740,000
1,771,000
Operating Income or Loss
1,083,000
1,105,000
1,165,000
1,159,000
1,065,000
Interest Expense
176,000
169,000
153,000
144,000
154,000
Total Other Income/Expenses Net
1,000
-12,000
16,000
70,000
191,000
Income Before Tax
911,000
926,000
1,030,000
1,086,000
1,103,000
Income Tax Expense
201,000
182,000
241,000
429,000
373,000
Income from Continuing Operations
761,000
788,000
824,000
696,000
753,000
Net Income
730,000
736,000
772,000
645,000
709,000
Net Income available to common shareholders
727,000
733,000
769,000
642,000
706,000
Reported EPS
Basic
-
5.39
5.63
4.58
4.92
Diluted
-
5.29
5.50
4.51
4.87
Weighted average shares outstanding
Basic
-
136,000
137,000
140,000
144,000
Diluted
-
139,000
140,000
142,000
145,000
EBITDA
-
1,404,000
1,453,000
1,479,000
1,561,000